Biomimetic composites represent a forward-looking direction in research, focus­ing on closely mimicking the natural microenvironment of tissues. Developing composites incorporating bioactive molecules, growth factors, and structural ele­ments resembling the extracellular matrix is gaining attention. Future research is expected to tailor these biomimetic composites to specic tissue types, enhancing tissue regeneration and repair [260]. This trend aligns with the broader goals of regenerative medicine and tissue engineering, aiming to create composite-based devices that seamlessly integrate with natural biological processes. Integrating composite- based drug delivery devices with personalized medicine approaches is an emerging trend with signicant promise. Researchers are exploring ways to tai­lor drug release proles based on individual patient characteristics, genetic informa­tion, and disease progression [261]. This involves developing patient-specic composite devices that account for variations in metabolism, drug response, and anatomical considerations. This trend aligns with the growing emphasis on person­alized healthcare, envisioning composite devices that offer customized therapeutic interventions for improved patient outcomes. Integrating biohybrid materials, com­bining synthetic and natural components, into composite-based drug delivery devices is an emerging frontier with the potential to enhance biocompatibility and tissue integration [262]. This bioinspired approach could mimic the intricate archi­tecture of native tissues, fostering improved compatibility and active contribution to tissue regeneration. This integration with principles of tissue engineering could redene composite devices, making them not only carriers of therapeutic agents but active participants in the regeneration and repair of tissues.